Evidence map›Paper›PMID 35890205›Full record

ArticlePharmaceutics2022

Photoinduced Antibacterial Activity and Cytotoxicity of CdS Stabilized on Mesoporous Aluminosilicates and Silicates.

Anna Stavitskaya, Eliza Sitmukhanova, Adeliya Sayfutdinova, Elnara Khusnetdenova, Kristina Mazurova, Kirill Cherednichenko, Ekaterina Naumenko, Rawil Fakhrullin

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Clays and Wound Healing.Materials (Basel, Switzerland) · 2024
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anna StavitskayaFunctional Aluminosilicate Nanomaterials Lab, Gubkin University, 119991 Moscow, Russia.ORCID 0000-0001-6094-7405
Eliza SitmukhanovaFunctional Aluminosilicate Nanomaterials Lab, Gubkin University, 119991 Moscow, Russia.
Adeliya SayfutdinovaFunctional Aluminosilicate Nanomaterials Lab, Gubkin University, 119991 Moscow, Russia.ORCID 0000-0003-0246-8371
Elnara KhusnetdenovaFunctional Aluminosilicate Nanomaterials Lab, Gubkin University, 119991 Moscow, Russia.
Kristina MazurovaFunctional Aluminosilicate Nanomaterials Lab, Gubkin University, 119991 Moscow, Russia.
Kirill CherednichenkoFunctional Aluminosilicate Nanomaterials Lab, Gubkin University, 119991 Moscow, Russia.ORCID 0000-0002-1868-8232
Ekaterina NaumenkoBionanotechnology Lab, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kreml uramı 18, 420008 Kazan, Republic of Tatarstan, Russia.ORCID 0000-0001-7388-7958
Rawil FakhrullinFunctional Aluminosilicate Nanomaterials Lab, Gubkin University, 119991 Moscow, Russia.ORCID 0000-0003-2015-7649
Gubkin Russian State University of Oil and Gas · RUKazan Federal University · RU

Funding

Russian Science Foundation 21-73-00299
6 · The paper itself

Abstract

Inactivation of bacteria under the influence of visible light in presence of nanostructured materials is an alternative approach to overcome the serious problem of the growing resistance of pathogenic bacteria to antibiotics. Cadmium sulfide quantum dots are superefficient photocatalytic material suitable for visible light transformation. In this work, CdS nanoparticles with size of less than 10 nm (QDs) were synthesized on the surface of natural and synthetic mesoporous aluminosilicates and silicates (halloysite nanotubes, MCM-41, MCM-41/Halloysite, SBA-15). Materials containing 5-7 wt.% of CdS were characterized and tested as agents for photocatalytic bacteria degradation of Gram-positive

Indexed as

halloysiteMCM-41photocatalysisquantum dotsS. aureusSBA-15visible light

Identifiers

PMID35890205
PMCPMC9317289
OpenAlexW4283267914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.